BIOLIFE SOLUTIONS INC 8-K

What Happened

• BioLife Solutions, Inc. filed a Form 8-K on March 2, 2026 (Item 7.01) to disclose that the company issued an investor presentation. The presentation is furnished as Exhibit 99.1 to the filing and was made available on the company’s investor website. The filing was signed by CFO Troy Wichterman.

Key Details

• Date of disclosure: March 2, 2026.
• Exhibit: Investor Presentation furnished as Exhibit 99.1 to the Form 8-K.
• Presentation link: https://investors.biolifesolutions.com/image/2025_BLFS_Investor_Presentation_vF_2026-02-26.pdf
• Filing notes Regulation FD Disclosure (Item 7.01); no financial statements or earnings were reported in this Form 8-K.

Why It Matters

• The company used a Regulation FD disclosure to share its investor presentation publicly, ensuring material information is broadly available to all investors at the same time. Retail investors should review the linked presentation for any updates to strategy, guidance, or other investor-relevant information. This filing itself does not contain earnings or new financial results — it is a distribution of the presentation content.